Creotech Instruments SA
WSE:CRI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Creotech Instruments SA
WSE:CRI
|
PL |
|
EQTEC PLC
LSE:EQT
|
IE |
|
E
|
EcoPro Materials Co Ltd
KRX:450080
|
KR |
|
Smit Holdings Ltd
HKEX:2239
|
HK |
|
Spring Valley Acquisition Corp II
NASDAQ:SVII
|
US |
|
A
|
Alfi Inc
OTC:ALFIQ
|
US |
|
S
|
Spur Corporation Ltd
XBER:S2J
|
ZA |
|
I
|
Ionic Brands Corp
CNSX:IONC
|
CA |
|
Oriental Aromatics Ltd
NSE:OAL
|
IN |
|
T
|
Tiger Brands Ltd
JSE:TBS
|
ZA |
|
R
|
RFM Corp
XPHS:RFM
|
PH |
|
Y
|
Yuanjie Semiconductor Technology Co Ltd
SSE:688498
|
CN |
|
H
|
Hanwha Galleria Corp
KRX:452260
|
KR |
|
Relicab Cable Manufacturing Ltd
BSE:539760
|
IN |
|
Tremor International Ltd
LSE:TRMR
|
IL |
|
Brigade Enterprises Ltd
NSE:BRIGADE
|
IN |
|
L
|
Laxmi Organic Industries Ltd
NSE:LXCHEM
|
IN |
|
Capita PLC
LSE:CPI
|
UK |
|
Audience Analytics Ltd
SGX:1AZ
|
SG |
|
Caitong Securities Co Ltd
SSE:601108
|
CN |
|
Abbvie Inc
NYSE:ABBV
|
US |
Balance Sheet
Balance Sheet Decomposition
Creotech Instruments SA
Creotech Instruments SA
Balance Sheet
Creotech Instruments SA
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
3
|
6
|
12
|
26
|
73
|
0
|
|
| Cash |
3
|
6
|
12
|
26
|
73
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
5
|
6
|
8
|
10
|
13
|
13
|
|
| Accounts Receivables |
4
|
5
|
7
|
5
|
6
|
0
|
|
| Other Receivables |
1
|
1
|
1
|
5
|
6
|
0
|
|
| Inventory |
2
|
1
|
5
|
9
|
10
|
9
|
|
| Other Current Assets |
6
|
10
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
16
|
23
|
24
|
45
|
95
|
55
|
|
| PP&E Net |
2
|
5
|
7
|
7
|
33
|
33
|
|
| PP&E Gross |
0
|
0
|
0
|
7
|
33
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
4
|
8
|
0
|
|
| Intangible Assets |
3
|
2
|
13
|
21
|
36
|
50
|
|
| Note Receivable |
1
|
0
|
0
|
0
|
3
|
15
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
2
|
5
|
0
|
|
| Total Assets |
21
N/A
|
31
+43%
|
46
+50%
|
75
+64%
|
173
+129%
|
162
-6%
|
|
| Liabilities | |||||||
| Accounts Payable |
5
|
6
|
5
|
10
|
21
|
22
|
|
| Accrued Liabilities |
4
|
9
|
2
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
3
|
5
|
1
|
2
|
2
|
|
| Other Current Liabilities |
4
|
4
|
1
|
2
|
2
|
5
|
|
| Total Current Liabilities |
15
|
21
|
13
|
13
|
24
|
30
|
|
| Long-Term Debt |
0
|
1
|
0
|
2
|
22
|
20
|
|
| Deferred Income Tax |
0
|
0
|
1
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
1
|
14
|
12
|
35
|
42
|
|
| Total Liabilities |
16
N/A
|
23
+47%
|
28
+18%
|
27
-3%
|
81
+202%
|
91
+12%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
3
|
1
|
1
|
8
|
15
|
21
|
|
| Additional Paid In Capital |
8
|
8
|
19
|
56
|
106
|
92
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
5
N/A
|
7
+33%
|
18
+153%
|
48
+166%
|
91
+88%
|
71
-22%
|
|
| Total Liabilities & Equity |
21
N/A
|
31
+43%
|
46
+50%
|
75
+64%
|
173
+129%
|
162
-6%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
2
|
2
|
2
|
2
|
2
|
2
|
|